Oral toxicities secondary to trop2 and her2 directed antibody drug conjugates (adcs) in patients with advanced-stage cancers.

Oral toxicities secondary to trop2 and her2 directed antibody drug conjugates (adcs) in patients with advanced-stage cancers.

Files

Publication Date

4-30-2026

Content Type

poster_control

Oral toxicities secondary to trop2 and her2 directed antibody drug conjugates (adcs) in patients with advanced-stage cancers.

Share

COinS